vai alle Pubblicazioni
Publications prior to 2004
1.
Fallo F, Rocco S, Pagotto
U, Zangari M, Luisetto G, Musaio F, Mantero F. Aldosterone and
pressor responses to angiotensin II in primary hyperparathyroidism.
Hormone and Metabolic
Research 8:457-459, 1989. IF:
2,25
2.
Pagotto U
, Milani R, Fallo F, Castellano M, Boscaro M, Mantero F. Effect of
Benazepril on
b
-endorphin in essential hypertension. Journal of Endocrinological
Investigation 12(Suppl.4):131-134, 1989. IF:
2,02
3.
Pistorello M, Chouman M, Pagotto U, Fallo F. Effect
of Captopril on aldosterone response to potassium infusion in
primary aldosteronism. Journal
of Hypertension 9(Suppl.6):S270-S271,
1991. IF:
4,36
4.
Boscaro
M, Rampazzo A, Paoletta A, Roseano P, Pagotto U, Fallo F, Sonino
N. Selective venous sampling in the differential diagnosis of
ACTH-dependent Cushing's syndrome. Neuroendocrinology
55:264-268, 1992. IF:
2,29
5.
Newton
CJ, Buric R, Trapp T, Brockmeier S, Pagotto U, Stalla GK. The
unliganded estrogen receptor (ER) transduces growth factor signals.
Journal of Steroid
Biochemistry and Molecular Biology 5/6:481-486, 1994. IF: 2,79
6.
Newton
CJ,
Trapp T, Pagotto U,
Renner U, Buric R, Stalla GK. The oestrogen receptor modulates
growth of pituitary tumour cells in absence of exogenous oestrogen.
Journal of Molecolar
Endocrinology 12:303-312, 1994. IF:
2,80
7.
Lange
M, Pagotto U, Hopfner
U, Ehrenreich H, Sinowatz F, Stalla GK. Endothelin expression in
normal human anterior pituitaries and pituitary adenoma. Journal of Clinical
Endocrinology & Metabolism 79:1864-1870, 1994. IF:
5,49
8.
Renner
U, Newton CJ, Pagotto
U, Sauer J, Arzt E, Stalla GK. Involvement of interleukin-1 and
interleukin-1 receptor antagonist in rat pituitary cell growth
regulation. Endocrinology
136:3186-3193, 1995. IF:
5,04
9.
Pagotto
U,
Arzberger T, Hopfner U, Sauer J, Renner U, Newton CJ, Lange M, Uhl
E, Weindl A, Stalla GK. Expression and localization of endothelin-1
and endothelin receptors in human meningiomas: evidence for a role
in tumoural growth. Journal
of Clinical Investigation 96: 2017-2025; 1995. IF: 16,91
10.
Pagotto U
, Arzberger T, Hopfner U, Weindl A, Stalla GK. Cellular
localization of endothelin receptor mRNAs (ETA and ETB) in brain
tumours and normal human brain. Journal of Cardiovascular
Pharmacology 26 (Suppl.3):S104-S106, 1995. IF:
2,02
11.
Fallo
F, Sonino N, Barzon L, Pistorello M, Pagotto U, Paoletta A,
Boscaro M. Effect of surgical treatment on hypertension in
Cushing's syndrome. American
Journal of Hypertension 9:77-80, 1995. IF:
3,10
12.
Renner U, Pagotto U,
Arzt E, Stalla GK. Autocrine
and paracrine roles of polypeptide growth factors, cytokines and
vasogenic substances in normal and tumorous pituitary function and
growth: a review. European
Journal of Endocrinology 135: 515-532, 1996. IF:
3,23
13.
Fallo
F, Pilon C, Barzon L, Pistorello M, Pagotto U, Altavilla G,
Boscaro M, Sonino N. Effects of taxol on the human NCI-H295
adrenocortical carcinoma cell line. Endocrine Research
22:709-715, 1996. IF:
0,97
14.
Rossi GP, Albertin G, Bova S, Belloni AS, Fallo F, Pagotto U, Trevisi L, Palú
G, Pessina AC, Nussdorfer GG. Autocrine-paracrine
role of endothelin-1 in the regulation of aldosterone synthase
expression and intracellular Ca2+ in human adrenocrtical carcinoma
NCI-H295 cells. Endocrinology
138:4421-4426, 1997. IF:
5,04
15.
Renner U, Arzberger T, Pagotto U, Leimgruber S,
Uhl E, Müller OA, Lange M, Weindl A, Stalla GK. Heterogenous
dopamine D2 receptor subtype mRNA expression in clinically
nonfunctioning pituitary adenomas. Journal of Clinical
Endocrinology & Metabolism 83:1368-1375, 1998. IF:
5,49
16.
Fallo
F, Pilon C, Barzon L, Pistorello M, Pagotto U, Altavilla G,
Boscaro M, Sonino N. Paclitaxel is an effective antiproliferative
agent on the human NCI-H295 adreno-cortical carcinoma cell line. Chemotherapy 44:129-134,
1998. IF:
1,50
17.
Sauer J, Renner U, Hopfner U, Lange M, Müller OA, Strasburger CJ,
Pagotto U, Arzt E,
Stalla GK. Interleukin-1beta
enhances interleukin-1 receptor antagonist content in human
somatotroph adenoma cell cultures. Journal of Clinical
Endocrinology & Metabolism 83:2429-2434, 1998. IF:
5,49
18.
Arzt E, Páez Pereda M, Perez Castro C, Pagotto U, Renner U,
Stalla GK. Pathophysiological
role of the cytokine network in the anterior pituitary gland. Frontiers in
Neuroendocrinology 20: 71-95, 1999. IF: 7,82
19.
Pagotto
U,
Arzberger T, Ciani E, Lezoualc'h F, Pilon C, Journot L, Spengler D,
Stalla GK. Inhibition of Zac1, a new gene differentially expressed
in the anterior pituitary, increases cell proliferation. Endocrinology 140: 987-996,
1999.IF:
5,36
20.
Gloddek
J, Pagotto U, Paez
Pereda M, Arzt E, Stalla GK, Renner U. Pituitary adenylate cyclase
activating polypeptide, interleukin-6 and glucocorticoids regulate
the release of vascular endothelial growth factor in pituitary
folliculostellate cells. Journal of Endocrinology 160; 483-490,
1999. IF:
2,58
21.
Páez Pereda M, Hopfner U, Pagotto U, Renner U, Arzt
E, Missale C, Stalla GK. Retinoic
acid stimulates meningioma cell adhesion to the extracellular
matrix and inhibits invasion. British Journal of Cancer
81: 381-386, 1999. IF:
4,63
22.
Pilon
C, Pistorello M, Moscon A, Altavilla G, Pagotto U, Boscaro M,
Fallo F. Inactivation of the p16 tumor suppressor gene in
adrenocortical tumors. Journal of Clinical
Endocrinology & Metabolism 84: 2776-2779, 1999. IF:
5,80
23.
Pagotto U
, Arzberger T, Theodoropoulou M, Grübler Y, Pantaloni C, Saeger W,
Losa M, Journot L, Stalla GK, Spengler D. The
expression of the antiproliferative gene ZAC is lost or highly
reduced in non-functioning pituitary adenomas Cancer Research 6794-6799,
2000. IF:
8,46
24.
Gambineri A, Pelusi C, Vicennati V, Pagotto U, Pasquali R.
Testosterone in aging men Expert Opinion on
Investigational Drugs 10: 477-482, 2001. IF: 3,06 (IF riferito al
2002)
25.
Pagotto U
, Marsicano G, Fezza F, Theodoropoulou M, Grübler Y, Stalla J,
Arzberger T, Milone A, Losa M, Di Marzo V, Lutz B, Stalla
GK. Normal
human pituitary gland and pituitary adenomas express cannabinoid
receptor type 1 and synthesize endogenous cannabinoids. First
evidence for a direct role of cannabinoids on hormone modulation at
the human pituitary level Journal of Clinical
Endocrinology & Metabolism 86:2687-2696, 2001. IF:
5,16
26.
Lohrer
P, Gloddek J, Hopfner U, Losa M, Uhl E, Pagotto U, Stalla GK,
Renner U. Vascular endothelial growth factor production and
regulation in rodent and human pituitary tumor cells in vitro. Neuroendocrinology
74:95-105, 2001. IF:
2,14
27.
Páez-Pereda
M, Kovalovsky D, Hopfner U, Theodoropoulou M, Pagotto U, Uhl E, Losa M,
Stalla J, Grübler Y, Missale C, Arzt E, Stalla GK. Retinoic acid
prevents experimental Cushing's syndrome. Journal of Clinical
Investigation. 108:1123-1131, 2001. IF: 14,11
28.
Winkelmann
J, Pagotto U,
Theodoropoulou M, Tatsch K, Saeger W, Muller A, Arzberger T, Schaaf
L, Schumann EM, Trenkwalder C, Stalla GK. Retention of dopamine 2
receptor mRNA and absence of the protein in craniospinal and
extracranial metastasis of a malignant prolactinoma: a case report.
European Journal of
Endocrinology. 146:81-88;2002. IF: 2,56
29.
Lange
M, Pagotto U, Renner U,
Arzberger T, Oeckler R, Stalla GK. The role of endothelins in the
regulation of pituitary function. Experimental and Clinical
Endocrinology & Diabetes. 110:103-112; 2002. IF:
1,43
30.
Gambineri A, Pelusi C, Vicennati V, Pagotto U, Pasquali R.
Obesity and the polycystic ovary syndrome. International
Journal of Obesity and Related Metabolic Disorders.
26:883-896; 2002 IF:
2,36
31. Pagotto
U,
Gambineri A, Vicennati V, Heiman ML, Tschöp M, Pasquali R. Plasma
ghrelin, obesity and the polycystic ovary syndrome: correlation
with insulin-resistance and androgen levels. Journal of Clinical
Endocrinology & Metabolism. 87:5625-5629; 2002. IF:
5,19
32.
Cota
D, Marsicano G, Lutz B, Vicennati V, Stalla GK, Pasquali R, Pagotto U. Endogenous
cannabinoid system as a modulator of food intake. International Journal of
Obesity and Related Metabolic Disorders. 27:289-301; 2003. IF: 2,79
33.
Cota
D, Marsicano G, Tschop M, Grubler Y, Flachskamm C, Schubert M, Auer
D, Yassouridis A, Thone-Reineke C, Ortmann S, Tomassoni F, Cervino
C, Nisoli E, Linthorst AC, Pasquali R, Lutz B, Stalla GK, Pagotto U. The endogenous
cannabinoid system affects energy balance via central orexigenic
drive and peripheral lipogenesis. Journal of Clinical
Investigation. 112:423-431; 2003. IF: 14,30
34.
Cavallari
I, D'Agostino DM, Ferro T, Rosato A, Barzon L, Pasquali C, Fogar P,
Theodoropoulou M, Esposito G, Boscaro M, Pagotto U, Tebaldi E,
Fallo F, Chieco-Bianchi L, Ciminale V. In situ analysis of human
menin in normal and neoplastic pancreatic tissues: evidence for
differential expression in exocrine and endocrine cells. Journal of Clinical
Endocrinology & Metabolism. 88:3893-3901; 2003. IF: 5,87
35.
Horvath
TL, Castaneda T, Tang-Christensen M, Pagotto U, Tschop MH.
Ghrelin as a potential anti-obesity target. Current Pharmacological
Design. 9:1383-1395; 2003. IF: 5,50
36.
Marsicano
G, Cota D, Stalla GK, Pasquali R, Pagotto U, Lutz B
Cannabinoids in energy balance and prospectives in the therapy of
obesity. Current Medical
& Chemicals of Central Nervous System agents 3:81-87; 2003.
no impact
37. Pagotto
U,
Gambineri A, Pelusi C, Genghini S, Cacciari M, Otto B, Castañeda T,
Tschöp M, Pasquali R. Testosterone replacement therapy restores
normal ghrelin in hypogonadal men Journal of Clinical
Endocrinology & Metabolism. 88:4139-4143; 2003.IF:
5,87
38.
Gambineri
A, Pagotto U, Tschöp M,
Vicennati V, Carcello A, Cacciari M, De Iasio R, Pasquali R.
Anti-androgen treatment increases circulating ghrelin levels in
obese women with polycystic ovary syndrome Journal of Endocrinological
Investigation. 26:629-634; 2003. IF: 1,62
39.
Schneider HJ, Pagotto
U, Stalla GK. Central effects of the somatotropic system. European Journal of
Endocrinology.149:377-392; 2003. IF: 2.94
40.
Cota
D, Genghini S, Pasquali R, Pagotto U. Antagonizing the
cannabinoid receptor type 1: a dual way to fight obesity. Journal of Endocrinological
Investigation. 26:1041-1044; 2003. IF: 1,62
41.
Marchesini
G, Pagotto U, Bugianesi
E, De Iasio R, Manini R, Vanni E, Pasquali R, Melchionda N,
Rizzetto M. Low ghrelin concentrations in non-alcoholic fatty liver
disease are related to insulin-resistance. Journal of Clinical
Endocrinology & Metabolism. 88:5674-5679; 2003. IF:
5,87
42.
Gambineri
A, Pelusi C, Genghini S, Morselli-Labate AM, Cacciari M, Pagotto U, Pasquali R.
Effect of flutamide and metformin administered alone or in
combination in dieting obese women with polycystic ovary syndrome.
Clinical Endocrinology
(Oxf). 60:241-249; 2004.
IF: 3,02
